China extends the use of Cuban anti-cancer drug
Clinical studies in 23 centers in the Asian giant validated the effectiveness of the monoclonal antibody Nimotuzumab. The anticancer drug used to treat pancreatic and nasopharyngeal carcinoma, Nimotuzumab, received approval…
Comments Off on China extends the use of Cuban anti-cancer drug
4 March 2024 11:56 AM